1 If other
direct-to-consumer ads were to communicate outcome data
2 Direct-to-consumer advertisement (DTCA) and physician pr
3 maceutical companies spent US$1.8 billion on
direct-to-consumer advertisements for prescription drugs
4 zed clinical trials to examine the impact of
direct-to-consumer advertisements on the efficacy of a b
5 Although cancer-related
direct-to-consumer advertising (CR-DTCA) is prevalent, l
6 Direct-to-consumer advertising (DTCA) also increased dur
7 tes is one of only two countries that permit
direct-to-consumer advertising (DTCA) of prescription dr
8 Content analysis of cancer-related
direct-to-consumer advertising (DTCA), with a focus on h
9 Finally, we documented the variation in
direct-to-consumer advertising among and within five the
10 s in spending by pharmaceutical companies on
direct-to-consumer advertising and promotion to physicia
11 Consumers see $4 billion of
direct-to-consumer advertising annually, which typically
12 Annual spending on
direct-to-consumer advertising for prescription drugs tr
13 Spending on
direct-to-consumer advertising has continued to increase
14 Although the use of
direct-to-consumer advertising has grown disproportionat
15 urinary incontinence have had mixed results;
direct-to-consumer advertising has increased public awar
16 Although during that time spending on
direct-to-consumer advertising increased by 330%, it mad
17 Evidence suggests that
direct-to-consumer advertising of prescription drugs inc
18 is public concern about the possibility that
direct-to-consumer advertising of prescription drugs wil
19 The initial surge in
direct-to-consumer advertising preceded the 1997 FDA gui
20 market areas, regional exposure to televised
direct-to-consumer advertising was associated with great
21 here is marked variation in the intensity of
direct-to-consumer advertising, and the amount of such a
22 ines that clarified the rules for electronic
direct-to-consumer advertising, and thus the 1997 guidel
23 to be responsible for unleashing a flood of
direct-to-consumer advertising.
24 Direct-to-consumer campaigns generally begin within a ye
25 iduals have access to raw genomic data using
direct-to-consumer companies.
26 dary Findings in the Clinical, Research, and
Direct-to-Consumer Contexts ) recommends that a research
27 on (tCS) is reflected by the recent surge in
direct-to-consumer device marketing, do-it-yourself enth
28 ectronic industries and have begun to market
direct-to-consumer DNA testing.
29 Although
direct-to-consumer (
DTC) advertisements for pharmaceutic
30 Increasing public interest in
direct-to-consumer (
DTC) genetic ancestry testing has be
31 ed for clinical use but is available through
direct-to-consumer (
DTC) genetic testing companies.
32 Direct-to-consumer (
DTC) genetic testing has attracted a
33 there have been notable developments in the
direct-to-consumer (
DTC) genomic testing arena, in parti
34 Direct-to-consumer (
DTC) personal genomic testing (PGT)
35 ug discovery efforts to big-data methods and
direct-to-consumer (
DTC) strategies.
36 known about the quality of rapidly expanding
direct-to-consumer (
DTC) telemedicine websites and smart
37 Personal genome tests are now offered
direct-to-consumer (
DTC) via genetic variants identified
38 cle, we discuss the rapidly evolving area of
direct-to-consumer genetic testing and the current utili
39 Here, we use data derived from
direct-to-consumer genetic testing to investigate patter
40 How the FDA should regulate
direct-to-consumer genetic tests is fiercely contested.
41 The use of
direct-to-consumer genomewide profiling to assess diseas
42 sed by commercial weight loss centers or for
direct-to-consumer marketing by manufacturers and does n
43 rtant questions about the appropriateness of
direct-to-consumer marketing for oncologic medications.
44 nd the high costs associated with screening,
direct-to-consumer marketing of helical CT is not advisa
45 Direct-to-consumer marketing of unapproved stem cell int
46 Encouraged by
direct-to-consumer marketing, smokers and their physicia
47 Moreover, the availability of
direct-to-consumer NGS services is fuelling a rise of 'c
48 offering tests using genome-wide technology
direct to consumers over the internet.
49 ruse of health care resources in response to
direct-to-consumer personal genomic testing (PGT).
50 Conclusion Most adults receiving elevated
direct-to-consumer PGT single nucleotide polymorphism-ba
51 Direct-to-consumer prescription drug ads typically fail
52 Direct-to-consumer promotion of lung cancer screening ha
53 Direct-to-consumer testing challenges many of the assump
54 One of the significant challenges of
direct-to-consumer testing is that it shifts the control